How Tiny RNAs Influence Vascular Dementia and Cognitive Decline
A Simple Explanation of a Scientific Review Paper
Original Paper: “Regulatory microRNAs and Vascular Cognitive Impairment and Dementia”
By Jing Zhang, Ping Sun, Chao Zhou, Xuejing Zhang, Feifei Ma, Yang Xu, Milton H. Hamblin & Ke-Jie Yin | CNS Neuroscience & Therapeutics, 2020
What Is This Paper About?
This 2020 review examines the role of microRNAs (miRNAs or miRs) in vascular cognitive impairment and dementia (VCID) — a form of cognitive decline caused by problems with blood flow in the brain. VCID is the second most common type of dementia after Alzheimer’s disease. The authors explain how these tiny RNA molecules contribute to the disease process and why they are promising targets for both diagnosis and future treatments.
What Is Vascular Cognitive Impairment and Dementia (VCID)?
VCID covers a spectrum of thinking and memory problems caused by damage to the brain’s blood vessels. It ranges from mild cognitive impairment to full dementia. Causes include strokes, silent (asymptomatic) infarcts, small-vessel disease, reduced blood flow over time (chronic cerebral hypoperfusion), and related conditions such as cerebral amyloid angiopathy.
Key pathological features include injury to the brain’s white matter (the long-distance “wiring” between brain regions), damage to gray matter (areas rich in neuron cell bodies, especially the hippocampus, which is critical for memory), disruption of the blood-brain barrier, inflammation, and oxidative stress. Currently, treatments mainly manage symptoms; no widely effective disease-modifying therapy exists.
How miRNAs Fit Into the Picture
miRNAs are short non-coding RNA molecules that act as post-transcriptional regulators — they bind to messenger RNA and reduce the production of specific proteins. Because one miRNA can influence many genes, and many miRNAs can act on the same pathway, they powerfully control complex processes such as inflammation, cell survival, blood-vessel integrity, and neuronal function.
In VCID, the levels of numerous miRNAs become abnormal in both the brain and the blood. These changes help drive (or sometimes try to counteract) the disease processes listed above. Experimental studies in animal models show that deliberately raising or lowering certain miRNAs can reduce brain damage and improve cognitive performance.
Main Ways miRNAs Influence VCID
According to the review, miRNAs affect VCID through several interconnected mechanisms:
- White-matter injury — affecting myelin, axons, and supporting glial cells
- Neuronal damage and loss — especially in memory-related regions such as the hippocampus
- Blood-brain barrier disruption — making the barrier more leaky and allowing harmful substances into the brain
- Neuroinflammation and oxidative stress — amplifying tissue damage
- Synaptic and network dysfunction — impairing communication between brain cells
Therapeutic and Diagnostic Potential
Because miRNA levels change in predictable ways in VCID, circulating miRNAs (found in blood or other fluids) are being explored as possible diagnostic or monitoring biomarkers. In the laboratory, both pharmacological and genetic methods that restore beneficial miRNA levels or suppress harmful ones have improved outcomes in animal models of VCID.
The authors highlight that targeting specific regulatory miRNAs represents a novel therapeutic strategy. Approaches could include miRNA mimics (to boost protective ones) or inhibitors (to block damaging ones). Delivery methods that reach the brain safely remain an active area of research.
The Big Picture
VCID is a major and growing cause of cognitive decline linked to blood-vessel problems in the aging brain. miRNAs sit at important control points in the molecular pathways that drive white-matter damage, neuronal injury, inflammation, and barrier dysfunction. By understanding and eventually modulating these tiny regulators, researchers hope to develop better ways to diagnose the condition earlier and slow or reverse its progression—something current treatments cannot yet achieve effectively.
Key Takeaways in Everyday Language
- VCID is cognitive decline caused by reduced or damaged blood supply to the brain and is the second most common form of dementia.
- miRNAs are tiny gene regulators whose levels become abnormal in VCID and help drive (or counteract) the disease process.
- They influence white-matter injury, neuron survival, blood-brain barrier integrity, inflammation, and oxidative stress.
- Changing specific miRNA levels in animal models can protect the brain and improve cognitive function.
- miRNAs are therefore promising candidates for both future diagnostic tests and new therapeutic approaches for VCID.
Original Citation
Zhang J., Sun P., Zhou C., Zhang X., Ma F., Xu Y., Hamblin M.H., Yin K.-J. (2020). Regulatory microRNAs and vascular cognitive impairment and dementia. CNS Neuroscience & Therapeutics, 26(12), 1207–1218.
DOI: 10.1111/cns.13472 | PMID: 33459504 | PMCID: PMC7702235
This summary is written in plain language for educational purposes and is not a substitute for reading the original scientific paper.
